BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24854395)

  • 1. Galectin-3 and PTEN expression in pancreatic ductal adenocarcinoma, pancreatic neuroendocrine neoplasms and gastrointestinal tumors on fine-needle aspiration cytology.
    Jiang K; Lawson D; Cohen C; Siddiqui MT
    Acta Cytol; 2014; 58(3):281-7. PubMed ID: 24854395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of phosphatase and tensin homolog expression is associated with recurrence and poor prognosis in patients with pancreatic ductal adenocarcinoma.
    Foo WC; Rashid A; Wang H; Katz MH; Lee JE; Pisters PW; Wolff RA; Abbruzzese JL; Fleming JB; Wang H
    Hum Pathol; 2013 Jun; 44(6):1024-30. PubMed ID: 23260327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of endoscopic ultrasound-guided fine needle aspiration in pretest prediction and diagnosis of pancreatic ductal adenocarcinoma].
    Wu L; Guo W; Li Y; Cheng T; Yao Y; Zhang Y; Liu B; Zhong M; Li S; Deng X; Zhu W
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1171-1178. PubMed ID: 30377133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of pancreatic juice cytology by using synthetic secretin in the diagnosis of pancreatic ductal adenocarcinoma.
    Takeda Y; Matsumoto K; Kurumi H; Koda H; Yamashita T; Onoyama T; Kawata S; Horie Y; Isomoto H
    Dig Endosc; 2018 Nov; 30(6):771-776. PubMed ID: 29873113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue transglutaminase regulates focal adhesion kinase/AKT activation by modulating PTEN expression in pancreatic cancer cells.
    Verma A; Guha S; Wang H; Fok JY; Koul D; Abbruzzese J; Mehta K
    Clin Cancer Res; 2008 Apr; 14(7):1997-2005. PubMed ID: 18381937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinically feasible multiplex proteomic immunoassay as a novel functional diagnostic for pancreatic ductal adenocarcinoma.
    Lim KH; Langley E; Gao F; Luo J; Li L; Meyer G; Kim P; Singh S; Kushnir VM; Early DS; Mullady DK; Edmundowicz SA; Wani S; Murad FM; Cao D; Azar RR; Wang-Gillam A
    Oncotarget; 2017 Apr; 8(15):24250-24261. PubMed ID: 28445954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic potential of hypermethylation of the cysteine dioxygenase 1 gene (CDO1) promoter DNA in pancreatic cancer.
    Nishizawa N; Harada H; Kumamoto Y; Kaizu T; Katoh H; Tajima H; Ushiku H; Yokoi K; Igarashi K; Fujiyama Y; Okuwaki K; Iwai T; Watanabe M; Yamashita K
    Cancer Sci; 2019 Sep; 110(9):2846-2855. PubMed ID: 31325200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical Antibody Panel for the Differential Diagnosis of Pancreatic Ductal Carcinoma From Gastrointestinal Contamination and Benign Pancreatic Duct Epithelium in Endoscopic Ultrasound-Guided Fine-Needle Aspiration.
    Furuhata A; Minamiguchi S; Shirahase H; Kodama Y; Adachi S; Sakurai T; Haga H
    Pancreas; 2017 Apr; 46(4):531-538. PubMed ID: 28099249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretest prediction and diagnosis of metastatic lesions to the pancreas by endoscopic ultrasound-guided fine needle aspiration.
    Krishna SG; Bhattacharya A; Ross WA; Ladha H; Porter K; Bhutani MS; Lee JH
    J Gastroenterol Hepatol; 2015 Oct; 30(10):1552-60. PubMed ID: 25867963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A microRNA-based test improves endoscopic ultrasound-guided cytologic diagnosis of pancreatic cancer.
    Brand RE; Adai AT; Centeno BA; Lee LS; Rateb G; Vignesh S; Menard C; Wiechowska-Kozłowska A; Bołdys H; Hartleb M; Sanders MK; Munding JB; Tannapfel A; Hahn SA; Stefańczyk L; Tsongalis GJ; Whitcomb DC; Conwell DL; Morisset JA; Gardner TB; Gordon SR; Suriawinata AA; Lloyd MB; Wylie D; Labourier E; Andruss BF; Szafranska-Schwarzbach AE
    Clin Gastroenterol Hepatol; 2014 Oct; 12(10):1717-23. PubMed ID: 24662333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A correlation study of mismatch repair immunohistochemical protein expression of pancreatic solid tumors in cytology cell blocks and matching surgical specimens.
    Teodosescu A; Chan I; Elder J; Wu M
    Diagn Cytopathol; 2021 Jun; 49(6):700-705. PubMed ID: 33615705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Maspin, CK17 and Ki-67 Immunophenotyping in Diagnosing of Pancreatic Ductal Adenocarcinoma in Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology.
    Mamdouh MM; Okasha H; Shaaban HAM; Hafez NH; El-Gemeie EH
    Asian Pac J Cancer Prev; 2021 Oct; 22(10):3299-3307. PubMed ID: 34711007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of immunohistochemical IMP3 expression in core needle biopsies of pancreatic ductal adenocarcinoma.
    Wachter DL; Schlabrakowski A; Hoegel J; Kristiansen G; Hartmann A; Riener MO
    Am J Surg Pathol; 2011 Jun; 35(6):873-7. PubMed ID: 21566520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MTA2-mediated inhibition of PTEN leads to pancreatic ductal adenocarcinoma carcinogenicity.
    Si W; Liu X; Wei R; Zhang Y; Zhao Y; Cui L; Hong T
    Cell Death Dis; 2019 Feb; 10(3):206. PubMed ID: 30814496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of pancreatic ductal adenocarcinoma with galectin-9 serum levels.
    Seifert AM; Reiche C; Heiduk M; Tannert A; Meinecke AC; Baier S; von Renesse J; Kahlert C; Distler M; Welsch T; Reissfelder C; Aust DE; Miller G; Weitz J; Seifert L
    Oncogene; 2020 Apr; 39(15):3102-3113. PubMed ID: 32055023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100P and XIAP expression in pancreatic ductal adenocarcinoma: potential novel biomarkers as a diagnostic adjunct to fine needle aspiration cytology.
    Kosarac O; Takei H; Zhai QJ; Schwartz MR; Mody DR
    Acta Cytol; 2011; 55(2):142-8. PubMed ID: 21325798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reevaluation and identification of the best immunohistochemical panel (pVHL, Maspin, S100P, IMP-3) for ductal adenocarcinoma of the pancreas.
    Liu H; Shi J; Anandan V; Wang HL; Diehl D; Blansfield J; Gerhard G; Lin F
    Arch Pathol Lab Med; 2012 Jun; 136(6):601-9. PubMed ID: 22646265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN alterations of the stromal cells characterise an aggressive subpopulation of pancreatic cancer with enhanced metastatic potential.
    Wartenberg M; Centeno I; Haemmig S; Vassella E; Zlobec I; Galván JA; Neuenschwander M; Schlup C; Gloor B; Lugli A; Perren A; Karamitopoulou E
    Eur J Cancer; 2016 Sep; 65():80-90. PubMed ID: 27475963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological significance of galectin-3 expression in ductal adenocarcinoma of the pancreas.
    Shimamura T; Sakamoto M; Ino Y; Shimada K; Kosuge T; Sato Y; Tanaka K; Sekihara H; Hirohashi S
    Clin Cancer Res; 2002 Aug; 8(8):2570-5. PubMed ID: 12171885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic influence of endoscopic ultrasound-guided fine needle aspiration in IPMN-derived invasive adenocarcinoma.
    Suzuki R; Irie H; Takagi T; Sugimoto M; Konno N; Sato Y; Watanabe K; Nakamura J; Marubashi S; Hikichi T; Ohira H
    BMC Cancer; 2018 Oct; 18(1):974. PubMed ID: 30314433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.